| Literature DB >> 31159283 |
Atul Kabra1,2, Natália Martins3,4, Rohit Sharma5, Ruchika Kabra6, Uttam Singh Baghel7.
Abstract
Myrica esculenta (Myricaceae) is a popular medicinal plant most commonly found in the sub-tropical Himalayas. It is widely used in folk medicine to treat several ailments such as asthma, cough, chronic bronchitis, ulcers, inflammation, anemia, fever, diarrhea, and ear, nose, and throat disorders. Due to its multidimensional pharmacological and therapeutic effects, it is well recognized in the ayurvedic pharmacopeia. However, the recent upsurge in M. esculenta use and demand has led to illicit harvesting by the horticultural trade and habitat loss, pushing the plant to the brink of extinction. Thus, the present review aims to provide updated information on M. esculenta botany, ethnomedicinal uses, phytochemistry, pharmacological effects, toxicity, and conservation methods, as well as also highlight prospective for future research. Particular emphasis is also given to its antioxidant potential in health promotion. In-depth literature was probed by searching several sources via online databases, texts, websites, and thesis. About 57 compounds were isolated and identified from M. esculenta, and the available reports on physicochemical parameters, nutritional and high-performance thin-layer chromatography analysis of bioactive plant parts are portrayed in a comparative manner. Friendly holistic conservation approaches offered by plant biotechnology applications, such as micropropagation, germplasm preservation, synthetic seed production, and hairy root technologies are also discussed. Nonetheless, further studies are needed to propose the mechanistic role of crude extracts and other bioactives, and even to explore the structure-function relationship of active components.Entities:
Keywords: Myrica esculenta; conservation; ethnomedicinal; kaphal; micropropagation; pharmacology; phytoconstituents
Year: 2019 PMID: 31159283 PMCID: PMC6631742 DOI: 10.3390/plants8060149
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Ayurvedic formulations of the plant with their uses and manufacturers.
| Formulation | Uses | Manufacturers | References |
|---|---|---|---|
| “Chwayanprash” | Improved digestion and strength and enhanced energy | Dabur, Patanjali, Nature & Nurture Healthcare | [ |
| “Katphaladi Churna” | Treatment of fever, throat infection, respiratory disorders, and abdominal pain | VHCA Ayurveda | [ |
| “Pushyanuga Churna” | Treatment for bleeding disorders and candidiasis | AVN Ayurveda,Baidyanat-h | [ |
| “Katphala Taila” | Treatment of joint pain | VHCA Ayurveda | [ |
| “Arimedadi Taila” | Helps to relieve tooth decay and breath problem | IMIS Pharmaceuticals | [ |
| “Mahavisagarbha Taila” | Used for vata imbalance, neuromuscular conditions | VHCA Ayurveda | [ |
| “Bala Taila” | Treatment of vata disorders, respiratory infections and weakness | Patanjali | [ |
| “Khadiradi Gutika” | Treatment of dental, oral, throat and tonsillar infections | Zandu | [ |
| “Maha Vatagajankusa Rasa” | Rheumatoid arthritis, Migraine, Paralysis, Cough, Cold, Asthma | Dabur, Baidyanath, Shree Dhootapapeshwar | [ |
| “Brihat Phala Ghrta” | Treatment of infertility | SN Pandit Ayurvedic | [ |
Figure 1Flow diagram of research methodology.
Figure 2Natural distribution of Myrica esculenta. The shaded area represents the natural habitat of M. esculenta in the India.
Figure 3Myrica esculenta (a) Whole plant; (b) Leaf; (c) Bark; (d) Fruit.
Ethomedicinal uses of M. esculenta.
| Plant Part Used | Uses | Region/Tribe | References |
|---|---|---|---|
|
| Jaundice | Meghalaya, India | [ |
|
| Inflammation of vocal cord | Meghalaya, India | [ |
|
| Antiseptic | Meghalaya, India | [ |
|
| Fever | Meghalaya, India | [ |
|
| Anemia | Meghalaya, India | [ |
|
| Refreshing drink “Um Soh-Phi” | Meghalaya, India | [ |
|
| Sore | Nagaland, India | [ |
|
| Toothache | Meghalaya, India | [ |
|
| Sprain | Far-flung village, Jajarkot, Nepal | [ |
|
| Inflammation, paralysis | Meghalaya, India | [ |
|
| Anthelmintic | Himachal Pradesh, India | [ |
|
| Bronchitis, dysentery | Nepalese community, Nepal | [ |
|
| Mental illness | Orissa, India | [ |
|
| Skin disorder | Vietnam, South China | [ |
|
| Cholera | Mizoram, India | [ |
|
| Cardiac debility, cardiac edema | Meghalaya, India | [ |
|
| Carminative | Meghalaya, India | [ |
|
| Asthma, chronic bronchitis, lung infection | Meghalaya, India | [ |
|
| Earache | Meghalaya, India | [ |
|
| Diarrhea, dysentery, stomach problem | Meghalaya, India | [ |
|
| Redness of mucosa | Chungtia village, Nagaland, India | [ |
|
| Body ache | Ukhimath block, Uttarakhand, India | [ |
|
| Headache | Mizoram, India | [ |
|
| Ulcer | Himalaya, India | [ |
Physiochemical parameters of different parts of M. esculenta.
| Parameters | Results | References | |||
|---|---|---|---|---|---|
| Leaves | Bark | Stem Bark | Small Branches | ||
|
| [ | ||||
| Methanolic extract | 28.32 | 38.52 | 23.57 | 5.03 | |
| Ethyl acetate extract | 25.46 | 21.20 | NR | NR | |
| Aqueous extract | 21.28 | 15.7 | 18.36 | 3.52 | |
|
| [ | ||||
| Total ash | 2.83 | 3.3312 | 1.010 | 1.856 | |
| Acid insoluble ash | 0.52 | 1.2300 | 0.187 | 0.320 | |
| Foreign matter (% w/w) | <1% | NR | Nil | Nil | |
| Loss on drying (%w/w) | 5 | 6.47 | 6.81 | ||
| Total phenolics mg of GAE/g d.w. | NR | NR | 276.78 ± 5.36 | 31.24 ± 2.57 | [ |
| Total flavonoids mg of QE/g d.w. | NR | NR | 121.68 ± 6.81 | 12.94 ± 1.12 | [ |
Mineral analyses of M. esculenta fruits and stem bark.
| Minerals (mg/g) | Fruit | Stem Bark | Reference |
|---|---|---|---|
| Calcium | 4.63 ± 0.06 | 3.155 ± 0.18 | [ |
| Potassium | 7.75 ± 0.11 | 2.939 ± 0.23 | [ |
| Magnesium | 8.4 ± 0.20 | 1.061 ± 0.4 | [ |
| Sodium | 0.81 ± 0.013 | 0.060 ± 0.03 | [ |
| Phosphorous | 0.24 ± 0.25 | 0.030 ± 0.01 | [ |
| Manganese | 0.032 ± 0.0001 | NR | [ |
| Iron | 0.404 ± 0.0021 | 0.123 ± 0.16 | [ |
| Zinc | 0.216 ± 0.0016 | 0.006 ± 0.001 | [ |
| Copper | 0.004 ± 0.0002 | NR | [ |
| Sulphur | NR | 0.277 ± 0.34 | [ |
HPTLC profile of various extracts of different parts of M. esculenta.
| Extract | Wavelength (nm) | Rf Value | References | ||
|---|---|---|---|---|---|
| Stem Bark | Small Branches | Leaves | |||
| n-hexane | 254 | 0.49, 0.69, 0.88 | 0.49, 0.78 | NR | [ |
| 366 | 0.42, 0.51, 0.59, 0.74, 0.83,0.91 | 0.42, 0.51, 0.74,0.83,0.91 | |||
| Ethyl acetate | 254 | 0.07, 0.12, 0.36, 0.47, 0.61, 0.67, 0.84 | 0.47, 0.67 | 0.15, 0.6, 0.8 | [ |
| 366 | 0.11, 0.15, 0.18, 0.33, 0.38, 0.55, 0.49, 0.65, 0.75, 0.85, 0.90 | 0.18, 0.30, 0.49, 0.65, 0.75, 0.85, 0.90 | 0.11, 0.22, 0.38, 0.53, 0.69, 0.82, 0.93 | ||
| Ethanol | 254 | 0.23, 0.54 | 0.23, 0.54 | NR | [ |
| 366 | 0.54, 0.73, 0.84 | 0.25, 0.45, 0.54, 0.73, 0.84 | |||
| Methanol | 254 | NR | NR | 0.625, 0.875 | [ |
| 366 | 0.46, 0.58, 0.81, 0.86, 0.93 | ||||
| Aqueous | 254 | NR | NR | 0.1, 0.63 | [ |
| 366 | 0.093, 0.65, 0.81 | ||||
Figure 4Structure of some isolated bioactive compounds from different parts of M. esculenta. (1) Gallic acid, (2) Epigallocatechin 3-O-gallate, (3) i) Epigallocatechin-(4β→8)-epigallocatechin-3-O-gallate, ii) 3-O-galloyl-epigallocatechin-(4β→8)-epigallocatechin-3-O-gallate, (4) Castalagin, (5) Catechin, (6) Chlorogenic acid, (7) p-coumaric acid, (8) Ethyl-β-D-glucopyranoside, (9) 3-hydroxybenzaldehyde, (10) Isovanillin, (11) Ferulic acid, (12) Myricetin, (13) i) Flavone 4′-hydroxy-3′,5,5′-trimethoxy-7-O-β-D-glucopyranosyl(1→4)-α-L-rhamnopyranoside, ii) flavone 3′,4′-dihydroxy-6-methoxy-7-O-α-L-rhamnopyranoside, (14) Myricitrin, (15) Lupeol, (16) Oleanolic acid, (17) Trihydroxytaraxaranoic acid, (18) Dihydroxytaraxerane, (19) Dihydroxytaraxaranoic acid, (20) Tetrahydroxytaraxenoic acid, (21) 3-epi-ursonic acid, (22) Prodelphinidin dimer, (23) Myricanol, (24) Myricanone.
Biological effects of M. esculenta.
| Part Use | Extract/Fraction | Dose Tested/Route of Administration | Animals/Cell Lines | Experimental Models | Result | Reference |
|---|---|---|---|---|---|---|
|
| ||||||
| Leaves | Methanolic | 200 mg/kg, p.o. | Rat | Carrageenan-induced rat paw edema | Significant anti-inflammatory activity | [ |
| Stem Bark | Essential oil | 10 mL per ear | Swiss albino mice | In vitro [ear] | Significant anti-inflammatory potential | [ |
| Leaves | ME- EtAC | 100, 200 and 400 mg/kg, p.o. | Wistar rats | Carrageenan-induced rat paw edema | Significant anti-inflammatory activity | [ |
| Bark | Ethyl acetate and aqueous | 100 and 200 mg/kg, p.o. | Wistar albino rats | Carrageenan and histamine induced rat paw edema | Significant anti-inflammatory potential (EAE> AE) | [ |
|
| ||||||
| Stem bark | Volatile oil | 10 mL | BP, SA, SE, EC, PA, CA, AN and SC | --- | Significant antimicrobial potential | [ |
| Bark and fruit | Methanolic and chloroform | --- | --- | Agar Well diffusion method | Significant antimicrobial potential (Bark> Fruits) | [ |
| Fruit pulp | Ethanolic | 10 and 50 mg/ml | In vitro | Disc diffusion assay | Dose dependent antimicrobial potential | [ |
| Fruit | Methanolic | 50 μL | SA, SE, BS, PM, EC, SE | Agar Well diffusion method | Significant potential against Pathogens | |
|
| ||||||
| Fruit | Methanolic, ethanolic and aqueous | 10 and 50mg/ml | Disc diffusion assay | Significant antifungal activity | [ | |
|
| ||||||
| Bark | 50% Aqueous Ethanolic | 12.5, 25 and 50 mg/ml | Earthworms ( | --- | Paralysis and death at 12.5 mg.ml | [ |
|
| ||||||
| Fruit | Methanol, acid methanol acetone and acidic acetone | 66.7, 166.5, 333, 500, 667 µg f.w./100 µL culture medium | C33A, SiHa and HeLa cell lines | --- | Acetone and acidic acetone extracts showed anticancer potential | [ |
| Fruit | Methanolic | 5mg/ml | HepG2, Hela and MDA-MB-231 cells | MTT assay | Moderate anticancer activity | [ |
|
| ||||||
| Bark | Ethanolic | 2.0 mg and 4.0 mg/kg | Swiss albino mice | Cumene hydroperoxide-mediated cutaneous oxidative stress and toxicity | ↑ antioxidant enzymes activity | [ |
|
| ||||||
| Fruit | Methanolic | --- | In vitro | DPPH, ABTS and FRAP assay | Significant antioxidant activity | [ |
| Fruit pulp | Methanolic | 0.10 ml | In vitro | DPPH, ABTS and FRAP assay | Good scavenging potential | [ |
| Fruit | Aqueous methanol and acetone | 100 µl | In vitro | DPPH assay | Acetone extract showed higher scavenging potential | [ |
| Fruit | Methanol, acidic methanol, acetone, and acidic-acetone | --- | In vitro | DPPH, ABTS, FRAP and Superoxide anion radicals scavenging assay | MeAA showed higher antimicrobial potential and MeAM and MeA intermediate | [ |
| Fruit | Fruit Juice | 0.2–2.0 mg/mL | In vitro | DPPH, H2O2 and NO scavenging activity | Moderate antioxidant activity | [ |
|
| ||||||
| Leaves | Methanolic | 50,100 and 150 mg/kg, p.o. | Albino wistar rats | STZ induced diabetes | Significant anti-dyslipidemic effect at 150 mg/kg and maintain blood glucose level | [ |
|
| ||||||
| Polyherbal formulation (Herbitars) | --- | 50 and 100 mg/kg | Wistar rat | CCl4 induced hepatotoxicity | Extract ↓TBARS, ↑SOD, CAT, GSH | [ |
|
| ||||||
| Bark | Methanolic | 300, 500 mg/kg, p.o. | Albino mice | Open field test, cage-crossing test, head-dip test, rearing test, traction test, forced swimming test | Significant antidepressant activity | [ |
|
| ||||||
| Bark | Ethanolic | 100, 200 and 400 mg/kg | Rats | Tail suspension test | Significant and dose dependent anxiolytic activity | [ |
| Forced swimming test | ||||||
|
| ||||||
| Leaves | Methanolic | 100 mM | In vitro | ACE inhibitory activity | Potent ACE inhibition potential | [ |
|
| ||||||
| Bark | Ethanolic | 75 mg/kg, p.o. | Guinea pig | Acetylcholine induced bronchospasm | Protection against bronchospasm and anaphylaxis | [ |
| Bark | Ethanolic | 75 mg/kg, p.o. | In vitro | Guinea pig tracheal strip | ↓pD2 value of histamine and acetylcholine | [ |
| Stem bark | Ethanolic | 150 mg/kg, p.o. | Guinea pig | Histamine induced bronchospasm | ↓TLC and DLC | [ |
| Stem Bark | Ethanolic | 75 and 150 mg/kg, p.o. | Mice | Acetic acid induced vascular permeability and allergic pleurisy | [ | |
| Stem bark | Aqueous extract | 27 & 54mg/kg p.o. | Guinea pig | histamine induced bronchospasm | Significant antiasthamtic potential | [ |
| In vitro | Guinea pig tracheal chain | |||||
| Bark | Polar, non-polar and methanolic | 200 mg/kg, p.o. | Rat and in vitro | Acetylcholine induced bronchospasm in conscious guinea pigs; acetylcholine induced contraction on isolated guinea pig tracheal chain preparation; compound 48/80 induced mast cell degranulation using rat; and trypsin and egg albumin induced bronchospasm | PE showed higher potential than NPE and ME | [ |
|
| ||||||
| Bark | Ethanolic | 100 and 200 mg/kg | Albino rat | Pyloric ligation induced ulcer | ↓level of GV, FA, LPO and GSH and ↑ CAT, nitrate and MPO↓level of GV, FA, LPO and GSH and ↑ CAT, nitrate and MPO | [ |
|
| ||||||
| Leaves | Ethanolic | 250 and 500 mg/kg, p.o. | Mice | Castor-oil induced diarrhea | Significant antidiarrheal activity | [ |
|
| ||||||
| Stem bark | Aqueous | 150 mg/kg | Male mice | Compound 48/80-induced | Significantly decrease in scratching effect | [ |
|
| ||||||
| Fruit | Methanolic | 50, 100 mg/kg, p.o. | Mice | Eddy’s hot plate method | Significant analgesic activity | [ |
| Leaves | ME-EtAC | 100, 200 mg/kg, p.o. | Mice | Acetic acid induced writhing and tail immersion assay | Significant response at 200 mg/kg | [ |
| Leaves | Methanolic | 200 mg/kg, p.o. | Mice | Acetic acid induced writhing | 54.56% inhibition of writhing | [ |
|
| ||||||
| Fruit | Methanolic | 50 and 100 mg/kg | Mice | Yeast induced pyrexia in mice | Significant antipyretic effect at 100 mg/kg | [ |
|
| ||||||
| Bark | Aqueous | Ointment (100 mg/500mm2) | Albino rats | Wound excision and incision | Significant wound healing potential | [ |